Nasal spray oil are also available. There is however no trial-verified evidence that they have a measurable effect on symptoms. Decongestant nasal sprays are available over-the-counter in many countries. They work to very quickly open up nasal passages by constricting blood vessels in the lining of the nose. Prolonged use of these types of sprays can damage the delicate mucous membranes in the nose. This causes increased inflammation, an effect known as rhinitis medicamentosa or the rebound effect. Decongestant nasal sprays are advised for short-term use only, preferably 5 to 7 days at maximum. Some doctors advise to use them 3 days
Nasal EPAP obstruction. Side effects that emerged during clinical trials included difficulty breathing, difficulty falling or staying asleep, dry mouth, nasal congestion, headache, difficulty putting on or removing the device, and anxiety. Ventus Medical received FDA 510K clearance for marketing the Provent EPAP device for OSA in 2009. Ventus received 510K clearance for an EPAP device to treat snoring in June 2012. Ventus was acquired by Theravent Inc. in 2013. Calik MW. Treatments for Obstructive Sleep Apnea. J Clin Outcomes Manag. 2016 Apr;23(4):181-192. Nasal EPAP Nasal expiratory positive airway pressure (Nasal EPAP) is a treatment for obstructive sleep apnea (OSA) and snoring.